Jie Wang

TL;DR: SLA 3DP technology allows the manufacture of drug loaded tablets with specific extended-release profiles and could become a manufacturing technology for the elaboration of oral dosage forms, for industrial production or even for personalised dose.

TL;DR: The study confirms the potential of 3D printing to fabricate multiple-drug containing devices with specialized design configurations and unique drug release characteristics, which would not otherwise be possible using conventional manufacturing methods.

TL;DR: SLA printing was the more appropriate 3D printing technology to manufacture anti-acne devices with salicylic acid and 3D scanning technology was used to obtain a 3D model of a nose adapted to the morphology of an individual.

TL;DR: The potential of combining FDM 3D printing technology with established pharmaceutical processes, including HME and film coating, to fabricate modified release oral dosage forms has been demonstrated.

TL;DR: This work has identified the molecular features in the structure of a wide range of peptides that influence their stability in the environment of the gastrointestinal tract, which in turn will allow for better selection of peptide candidates for oral delivery.